US2018228746A1PendingUtilityA1

Medications For Deposition On Biological Surfaces

57
Assignee: PROCTER & GAMBLEPriority: Apr 23, 2014Filed: Apr 5, 2018Published: Aug 16, 2018
Est. expiryApr 23, 2034(~7.8 yrs left)· nominal 20-yr term from priority
A61P 43/00A61K 31/4402A61Q 11/00A23V 2002/00A61K 9/06A61Q 5/12A61K 31/137A61K 31/485A61K 8/42A61K 9/0043C07C 323/33A61K 31/09A61P 1/02A61Q 5/02A61Q 19/00A61K 31/165A61K 9/28A61K 8/27A61K 2800/244A23G 4/06C07C 233/75A61Q 9/02A61K 8/46A61K 31/167A61K 8/34C07C 255/44C07C 233/73C07C 237/10A61K 9/0014A61K 9/0078A61K 31/192C07C 237/24
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Personal care compositions, such as oral medication compositions containing a flavor system comprising one or more coolants. The pleasant cool sensation provided by a coolant is enhanced in terms of quicker onset, greater intensity, impact or longer duration, which improves appeal and acceptability of the compositions to consumers.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A personal care composition providing a cool sensation wherein the composition comprises a compound comprising the following structure: 
       
         
           
           
               
               
           
         
       
     
     
         2 . The personal care composition of  claim 1 , wherein the compound activates at least one of TRPA1, TRPV1, or TRPM8. 
     
     
         3 . The personal care composition of  claim 2 , wherein the compound at a concentration of about 0.004% provides greater activation of TRPM8 than WS5 at a concentration of about 30 mM. 
     
     
         4 . The personal care composition of  claim 2 , wherein the compound at a concentration of about 0.02% provides greater activation of TRPA1 than allyl isothiocyanate at a concentration of about 50 mM. 
     
     
         5 . The personal care composition of  claim 2 , wherein the compound at a concentration of about 0.004% provides at least about 110% activation of TRPM8 when compared to WS5 at a concentration of about 30 mM. 
     
     
         6 . The personal care composition of  claim 2 , wherein the compound at a concentration of about 0.02% provides at least about 170% activation of TRPA1 when compared to allyl isothiocyanate at a concentration of about 50 mM. 
     
     
         7 . The personal care composition of  claim 1 , wherein the composition is selected from the group consisting of an oral care composition, a leave-on skin lotion, a shampoo, a body wash, an ointment, a feminine care composition, a baby care composition, and combinations thereof. 
     
     
         8 . The personal care composition of  claim 1  comprising a TRPM8 agonist. 
     
     
         9 . The personal care composition of  claim 1  comprising at least one of a TRPA1 agonist or a TRPV1 agonist.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.